HOOKIPA Pharma Inc. (HOOK)

HOOKIPA Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	59.75	117.1	112.49	65.92	142.74	113.15
Cash & Short-Term Investments	59.75	117.1	112.49	65.92	142.74	113.15
Cash Growth	-44.51%	4.10%	70.64%	-53.82%	26.15%	132.92%
Accounts Receivable	0.32	0.51	6.53	6.9	5.54	1.54
Other Receivables	24.67	18.76	15.48	14.27	15.12	8.19
Receivables	24.99	19.27	22.01	21.17	20.66	9.73
Prepaid Expenses	8.42	10.75	12.16	14.48	8.1	5.14
Restricted Cash	-	-	0.54	0.57	-	-
Total Current Assets	93.16	147.12	147.2	102.14	171.5	128.02
Property, Plant & Equipment	9.72	13.22	21.98	22.12	13.97	14.6
Other Long-Term Assets	6.85	1.01	1.28	1.8	2.34	1.13
Total Assets	109.73	161.34	170.45	126.05	187.82	143.75
Accounts Payable	8.96	12.5	5.49	8.76	8.01	0.94
Accrued Expenses	12.19	11.67	10.65	8.16	6.35	3.63
Current Portion of Long-Term Debt	-	1.12	1.59	2.79	-	1.22
Current Portion of Leases	1.21	1.64	1.69	1.7	2.15	1.97
Current Income Taxes Payable	-	0.37	0.23	-	-	-
Current Unearned Revenue	5.33	14.68	15.98	6.23	4.63	4.32
Other Current Liabilities	0.89	0.01	-	0.01	-	2.67
Total Current Liabilities	28.57	41.99	35.63	27.65	21.14	14.76
Long-Term Debt	-	-	0.91	2.22	4.54	3.5
Long-Term Leases	1.62	3.8	2.31	3.91	4.08	5.66
Long-Term Unearned Revenue	1.68	19.67	25.66	0.02	0.78	0.07
Other Long-Term Liabilities	6.06	6.02	3.42	2.65	1.15	1.87
Total Liabilities	37.93	71.48	67.94	36.45	31.69	25.85
Common Stock	0	0.01	0.01	0	0	0
Additional Paid-In Capital	468.2	467.04	397.35	317.14	309.29	225.57
Retained Earnings	-387.81	-369.26	-287.68	-222.77	-147.1	-103.02
Comprehensive Income & Other	-8.58	-7.93	-7.16	-4.78	-6.07	-4.65
Total Common Equity	71.8	89.86	102.52	89.59	156.12	117.9
Shareholders' Equity	71.8	89.86	102.52	89.59	156.12	117.9
Total Liabilities & Equity	109.73	161.34	170.45	126.05	187.82	143.75
Total Debt	2.83	6.56	6.5	10.63	10.77	12.35
Net Cash (Debt)	56.93	110.54	105.99	55.3	131.98	100.8
Net Cash Growth	-45.17%	4.29%	91.67%	-58.10%	30.93%	128.12%
Net Cash Per Share	4.66	11.69	16.18	16.84	50.68	56.44
Filing Date Shares Outstanding	12.05	12.05	7.63	8.91	6.42	6
Total Common Shares Outstanding	12.05	12.05	7.63	6.56	6.41	5.99
Working Capital	64.59	105.13	111.56	74.48	150.36	113.26
Book Value Per Share	5.96	7.45	13.43	13.66	24.34	19.67
Tangible Book Value	71.8	89.86	102.52	89.59	156.12	117.9
Tangible Book Value Per Share	5.96	7.45	13.43	13.66	24.34	19.67
Land	2.04	2.03	1.96	2.07	-	-
Machinery	11.93	12.03	10.06	9.55	7.97	6
Construction In Progress	0.02	0.21	10.57	7.75	0.03	0.29
Leasehold Improvements	3.33	3.3	3.16	3.35	3.32	1.92

Source: S&P Capital IQ. Standard template. Financial Sources.